Repsol, S.A.
Repsol, S.A. (REPYY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Repsol, S.A. (REPYY), featuring income statements, balance sheets, and cash flow data.
Repsol, S.A. (REPYY) Income Statement & Financial Overview
View the income breakdown for Repsol, S.A. REPYY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $14.41B | $27.20B | $13.70B | $14.74B |
| Cost of Revenue | $11.78B | $22.24B | $11.53B | $11.82B |
| Gross Profit | $2.62B | $4.96B | $2.16B | $2.92B |
| Gross Profit Ratio | $0.18 | $0.18 | $0.16 | $0.20 |
| R&D Expenses | $0.00 | $68.00M | $0.00 | $0.00 |
| SG&A Expenses | $398.00M | $1.21B | $385.00M | $429.00M |
| Operating Expenses | $2.05B | $5.42B | $1.95B | $1.84B |
| Total Costs & Expenses | $13.84B | $27.66B | $13.48B | $13.66B |
| Interest Income | $72.00M | $238.00M | $78.00M | $63.00M |
| Interest Expense | $77.00M | $335.00M | $117.00M | $124.00M |
| Depreciation & Amortization | $641.00M | $830.00M | $724.00M | $702.00M |
| EBITDA | $1.37B | $804.00M | $1.06B | $1.82B |
| EBITDA Ratio | $0.10 | $0.03 | $0.08 | $0.12 |
| Operating Income | $570.00M | -$462.00M | $210.00M | $1.08B |
| Operating Income Ratio | $0.04 | -$0.02 | $0.02 | $0.07 |
| Other Income/Expenses (Net) | $97.00M | $101.00M | $60.00M | -$27.00M |
| Income Before Tax | $667.00M | -$361.00M | $270.00M | $1.02B |
| Income Before Tax Ratio | $0.05 | -$0.01 | $0.02 | $0.07 |
| Income Tax Expense | $274.00M | -$321.00M | $43.00M | $430.00M |
| Net Income | $366.00M | $130.00M | $166.00M | $657.00M |
| Net Income Ratio | $0.03 | $0.005 | $0.01 | $0.04 |
| EPS | $0.31 | $0.10 | $0.13 | $0.56 |
| Diluted EPS | $0.31 | $0.10 | $0.13 | $0.56 |
| Weighted Avg Shares Outstanding | $1.18B | $1.30B | $1.14B | $1.18B |
| Weighted Avg Shares Outstanding (Diluted) | $1.18B | $1.30B | $1.14B | $1.18B |
The company's financials show resilient growth, with revenue advancing from $14.74B in Q2 2024 to $14.41B in Q1 2025. Gross profit remained healthy with margins at 18% in Q1 2025 compared to 20% in Q2 2024. Operating income hit $570.00M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.37B. Net income rose to $366.00M, while earnings per share reached $0.31. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan